SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris

SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of investigative dermatology 2023-08, Vol.143 (8), p.1601-1604
Hauptverfasser: Fenizia, Claudio, Moltrasio, Chiara, Ottobrini, Luisa, Utyro, Olga, Genovese, Giovanni, Vanetti, Claudia, Trabattoni, Daria, Marzano, Angelo V.
Format: Artikel
Sprache:eng
Schlagworte:
Letters to the Editor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1604
container_issue 8
container_start_page 1601
container_title Journal of investigative dermatology
container_volume 143
creator Fenizia, Claudio
Moltrasio, Chiara
Ottobrini, Luisa
Utyro, Olga
Genovese, Giovanni
Vanetti, Claudia
Trabattoni, Daria
Marzano, Angelo V.
description
doi_str_mv 10.1016/j.jid.2022.12.023
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9883068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022202X23000295</els_id><sourcerecordid>2771334474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-b70ffb20c1760f80bf8871cbd3f8256988c2ae808732e7bd5b87c40dad6212d93</originalsourceid><addsrcrecordid>eNp9UctqGzEUFaWlcZN-QDdllt3MRI-ZkUyhYEyaBgINSWq6E3pcOTLjGVeaMc3f56ZOQ7vJSnDPQ4dzCPnAaMUoa0831Sb6ilPOK8YrysUrMmMNFyWTtXxNZhSREuGfR-RdzhuKmrpRb8mRaCVr57yeEXOzuL4pl8Oq5MXKOBd7M8ahL85CADfGPfSQcxH74jqO0--4Nba8TWBG8MUVMqEfc7H4w8WLvS-uYLu7i-spF6upW5sU8wl5E0yX4f3Te0x-fD27XX4rL7-fXywXl6WrGzaWVtIQLKeOyZYGRW1QSjJnvQiKN-1cKccNKKqk4CCtb6ySrqbe-JYz7ufimHw5-O4muwXvMFoynd4lDJ3u9WCi_h_p451eD3uN1oK2Cg0-PRmk4dcEedTbmB10nelhmLLmUjIh6lrWSGUHqktDzgnC8zeM6sdp9EbjNPpxGs24xmlQ8_HffM-Kv1sg4fOBANjSPkLS2WHBDnxM2K_2Q3zB_gHYT6Az</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2771334474</pqid></control><display><type>article</type><title>SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fenizia, Claudio ; Moltrasio, Chiara ; Ottobrini, Luisa ; Utyro, Olga ; Genovese, Giovanni ; Vanetti, Claudia ; Trabattoni, Daria ; Marzano, Angelo V.</creator><creatorcontrib>Fenizia, Claudio ; Moltrasio, Chiara ; Ottobrini, Luisa ; Utyro, Olga ; Genovese, Giovanni ; Vanetti, Claudia ; Trabattoni, Daria ; Marzano, Angelo V.</creatorcontrib><identifier>ISSN: 0022-202X</identifier><identifier>EISSN: 1523-1747</identifier><identifier>DOI: 10.1016/j.jid.2022.12.023</identifier><identifier>PMID: 36716924</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Letters to the Editor</subject><ispartof>Journal of investigative dermatology, 2023-08, Vol.143 (8), p.1601-1604</ispartof><rights>2023 The Authors</rights><rights>2023 The Authors 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-b70ffb20c1760f80bf8871cbd3f8256988c2ae808732e7bd5b87c40dad6212d93</citedby><cites>FETCH-LOGICAL-c451t-b70ffb20c1760f80bf8871cbd3f8256988c2ae808732e7bd5b87c40dad6212d93</cites><orcidid>0000-0003-4490-6675 ; 0000-0002-9571-6057 ; 0000-0001-9535-3359 ; 0000-0003-0060-5870 ; 0000-0002-7636-958X ; 0000-0002-5002-6845 ; 0000-0002-8160-4169 ; 0000-0003-0735-8331</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36716924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fenizia, Claudio</creatorcontrib><creatorcontrib>Moltrasio, Chiara</creatorcontrib><creatorcontrib>Ottobrini, Luisa</creatorcontrib><creatorcontrib>Utyro, Olga</creatorcontrib><creatorcontrib>Genovese, Giovanni</creatorcontrib><creatorcontrib>Vanetti, Claudia</creatorcontrib><creatorcontrib>Trabattoni, Daria</creatorcontrib><creatorcontrib>Marzano, Angelo V.</creatorcontrib><title>SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris</title><title>Journal of investigative dermatology</title><addtitle>J Invest Dermatol</addtitle><subject>Letters to the Editor</subject><issn>0022-202X</issn><issn>1523-1747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9UctqGzEUFaWlcZN-QDdllt3MRI-ZkUyhYEyaBgINSWq6E3pcOTLjGVeaMc3f56ZOQ7vJSnDPQ4dzCPnAaMUoa0831Sb6ilPOK8YrysUrMmMNFyWTtXxNZhSREuGfR-RdzhuKmrpRb8mRaCVr57yeEXOzuL4pl8Oq5MXKOBd7M8ahL85CADfGPfSQcxH74jqO0--4Nba8TWBG8MUVMqEfc7H4w8WLvS-uYLu7i-spF6upW5sU8wl5E0yX4f3Te0x-fD27XX4rL7-fXywXl6WrGzaWVtIQLKeOyZYGRW1QSjJnvQiKN-1cKccNKKqk4CCtb6ySrqbe-JYz7ufimHw5-O4muwXvMFoynd4lDJ3u9WCi_h_p451eD3uN1oK2Cg0-PRmk4dcEedTbmB10nelhmLLmUjIh6lrWSGUHqktDzgnC8zeM6sdp9EbjNPpxGs24xmlQ8_HffM-Kv1sg4fOBANjSPkLS2WHBDnxM2K_2Q3zB_gHYT6Az</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Fenizia, Claudio</creator><creator>Moltrasio, Chiara</creator><creator>Ottobrini, Luisa</creator><creator>Utyro, Olga</creator><creator>Genovese, Giovanni</creator><creator>Vanetti, Claudia</creator><creator>Trabattoni, Daria</creator><creator>Marzano, Angelo V.</creator><general>Elsevier Inc</general><general>The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4490-6675</orcidid><orcidid>https://orcid.org/0000-0002-9571-6057</orcidid><orcidid>https://orcid.org/0000-0001-9535-3359</orcidid><orcidid>https://orcid.org/0000-0003-0060-5870</orcidid><orcidid>https://orcid.org/0000-0002-7636-958X</orcidid><orcidid>https://orcid.org/0000-0002-5002-6845</orcidid><orcidid>https://orcid.org/0000-0002-8160-4169</orcidid><orcidid>https://orcid.org/0000-0003-0735-8331</orcidid></search><sort><creationdate>20230801</creationdate><title>SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris</title><author>Fenizia, Claudio ; Moltrasio, Chiara ; Ottobrini, Luisa ; Utyro, Olga ; Genovese, Giovanni ; Vanetti, Claudia ; Trabattoni, Daria ; Marzano, Angelo V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-b70ffb20c1760f80bf8871cbd3f8256988c2ae808732e7bd5b87c40dad6212d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Letters to the Editor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fenizia, Claudio</creatorcontrib><creatorcontrib>Moltrasio, Chiara</creatorcontrib><creatorcontrib>Ottobrini, Luisa</creatorcontrib><creatorcontrib>Utyro, Olga</creatorcontrib><creatorcontrib>Genovese, Giovanni</creatorcontrib><creatorcontrib>Vanetti, Claudia</creatorcontrib><creatorcontrib>Trabattoni, Daria</creatorcontrib><creatorcontrib>Marzano, Angelo V.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of investigative dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fenizia, Claudio</au><au>Moltrasio, Chiara</au><au>Ottobrini, Luisa</au><au>Utyro, Olga</au><au>Genovese, Giovanni</au><au>Vanetti, Claudia</au><au>Trabattoni, Daria</au><au>Marzano, Angelo V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris</atitle><jtitle>Journal of investigative dermatology</jtitle><addtitle>J Invest Dermatol</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>143</volume><issue>8</issue><spage>1601</spage><epage>1604</epage><pages>1601-1604</pages><issn>0022-202X</issn><eissn>1523-1747</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36716924</pmid><doi>10.1016/j.jid.2022.12.023</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-4490-6675</orcidid><orcidid>https://orcid.org/0000-0002-9571-6057</orcidid><orcidid>https://orcid.org/0000-0001-9535-3359</orcidid><orcidid>https://orcid.org/0000-0003-0060-5870</orcidid><orcidid>https://orcid.org/0000-0002-7636-958X</orcidid><orcidid>https://orcid.org/0000-0002-5002-6845</orcidid><orcidid>https://orcid.org/0000-0002-8160-4169</orcidid><orcidid>https://orcid.org/0000-0003-0735-8331</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-202X
ispartof Journal of investigative dermatology, 2023-08, Vol.143 (8), p.1601-1604
issn 0022-202X
1523-1747
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9883068
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Letters to the Editor
title SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A52%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SARS-CoV-2%20Vaccination%20Effectiveness%20in%20Rituximab-Treated%20Patients%20Affected%20by%20Pemphigus%20Vulgaris&rft.jtitle=Journal%20of%20investigative%20dermatology&rft.au=Fenizia,%20Claudio&rft.date=2023-08-01&rft.volume=143&rft.issue=8&rft.spage=1601&rft.epage=1604&rft.pages=1601-1604&rft.issn=0022-202X&rft.eissn=1523-1747&rft_id=info:doi/10.1016/j.jid.2022.12.023&rft_dat=%3Cproquest_pubme%3E2771334474%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2771334474&rft_id=info:pmid/36716924&rft_els_id=S0022202X23000295&rfr_iscdi=true